BIOFORCE Nanosciences Issues Restricted Shares for $2.48M Services

What Happened
BIOFORCE Nanosciences Holdings, Inc. (BFNH) filed an 8-K on September 4, 2026 (Item 3.02) announcing it issued restricted common shares in a private placement as payment for services valued at $2,484,300. The shares were issued under the Section 4(2) exemption from registration and were not offered publicly due to the limited number of recipients and the manner of the offering. Purchasers represented they had the required investment intent; shares issued in book form will be noted as restricted and certificated shares will bear a Rule 144 legend.

Key Details

• Filing date: September 4, 2026 (Form 8-K, Item 3.02).
• Consideration: Restricted shares issued in exchange for services valued at $2,484,300.
• Offering: Private placement under Section 4(2) of the Securities Act — not a public offering; limited recipients.
• Restrictions/fees: Shares will be marked restricted (book or legend per Rule 144); the Company paid no commissions or fees in connection with the sales.

Why It Matters
This transaction represents non‑cash compensation to parties who provided services worth $2.48M. For investors, the issuance can increase the number of outstanding shares (potential dilution) and will be reflected in future company disclosures and financial statements. Retail investors should watch upcoming filings (e.g., next 10‑Q/10‑K) for details on the number of shares issued, accounting treatment, and any impact on ownership percentages.